Global and United States Live Attenuated Vaccine In-Depth Research Report 2017-2022

Published: Aug, 2017 | Pages: 103 | Publisher: US Market Insight (UMI)
Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)

The report is based on the market historical data from 2012 to 2016 and forecast the market trend from 2017 to 2022.

This report focuses on the U.S. market and presents volume and value of market share by players, by regions, by product type, by consumers and also changes in prices. As an in-depth report, it covers all details inside analysis and opinions in Live Attenuated Vaccine industry.

Major Companies

•	Astellas Pharma (Japan)
•	CSL Limited (Australia)
•	Emergent BioSolutions (U.S.)
•	GlaxoSmithKline (U.K.)
•	Johnson & Johnson (U.S.)
•	MedImmune (U.S.)
•	Merck & Co (U.S.)
•	Pfizer (U.S.)
•	Sanofi Pasteur (France)
•	Serum Institute of India Pvt (India)

Key Regions

•	North America
•	United States
•	California
•	Texas
•	New York
•	Others
•	Canada
•	Latin America
•	Mexico
•	Brazil
•	Argentina
•	Others
•	Europe
•	Germany
•	United Kingdom
•	France
•	Italy
•	Spain
•	Russia
•	Netherland
•	Others
•	Asia & Pacific
•	China
•	Japan
•	India
•	Korea
•	Australia
•	Southeast Asia
•	Indonesia
•	Thailand
•	Philippines
•	Vietnam
•	Singapore
•	Malaysia
•	Others
•	Africa & Middle East
•	South Africa
•	Egypt
•	Turkey
•	Saudi Arabia
•	Iran
•	Others

Main types of products

Live Attenuated Vaccine Market, by End User

•	Pediatrics
•	Adults

Live Attenuated Vaccine Market, by Disease Indication

•	Pneumococcal
•	Influenza
•	HPV
•	Hepatitis
•	Rotavirus

Live Attenuated Vaccine Market, by Key Consumers

•	Hospital
•	Medical Center
•	Others

 Table of Contents

Global and United States Live Attenuated Vaccine In-Depth Research Report 2017-2022

Chapter One Global Live Attenuated Vaccine Market Overview
    1.1 Global Live Attenuated Vaccine Market Sales Volume Revenue and Price 2012-2017
    1.2 Live Attenuated Vaccine, by End User 2012-2017
        1.2.1 Global Live Attenuated Vaccine Sales Market Share by End User 2012-2017
        1.2.2 Global Live Attenuated Vaccine Revenue Market Share by End User 2012-2017
        1.2.3 Global Live Attenuated Vaccine Price by End User 2012-2017
        1.2.4 Pediatrics
        1.2.5 Adults
    1.3 Live Attenuated Vaccine, by Disease Indication 2012-2017
        1.3.1 Global Live Attenuated Vaccine Sales Market Share by Disease Indication 2012-2017
        1.3.2 Global Live Attenuated Vaccine Revenue Market Share by Disease Indication 2012-2017
        1.3.3 Global Live Attenuated Vaccine Price by Disease Indication 2012-2017
        1.3.4 Pneumococcal
        1.3.5 Influenza
        1.3.6 HPV
        1.3.7 Hepatitis
        1.3.8 Rotavirus

Chapter Two United States Live Attenuated Vaccine Market Overview
    2.1 United States Live Attenuated Vaccine Market Sales Volume Revenue and Price 2012-2017
    2.2 Live Attenuated Vaccine, by End User 2012-2017
        2.2.1 United States Live Attenuated Vaccine Sales Market Share by End User 2012-2017
        2.2.2 United States Live Attenuated Vaccine Revenue Market Share by End User 2012-2017
        2.2.3 United States Live Attenuated Vaccine Price by End User 2012-2017
        2.2.4 Pediatrics
        2.2.5 Adults
    2.3 Live Attenuated Vaccine, by Disease Indication 2012-2017
        2.3.1 United States Live Attenuated Vaccine Sales Market Share by Disease Indication 2012-2017
        2.3.2 United States Live Attenuated Vaccine Revenue Market Share by Disease Indication 2012-2017
        2.3.3 United States Live Attenuated Vaccine Price by Disease Indication 2012-2017
        2.3.4 Pneumococcal
        2.3.5 Influenza
        2.3.6 HPV
        2.3.7 Hepatitis
        2.3.8 Rotavirus

Chapter Three Live Attenuated Vaccine by Regions 2012-2017
    3.1 Global Live Attenuated Vaccine Sales Market Share by Regions 2012-2017
    3.2 Global Live Attenuated Vaccine Revenue Market Share by Regions 2012-2017
    3.3 Global Live Attenuated Vaccine Price by Regions 2012-2017
    3.4 North America
        3.4.1 United States
            3.4.1.1 California
            3.4.1.2 Texas
            3.4.1.3 New York
            3.4.1.4 Others in United States
        3.4.2 Canada
    3.5 Latin America
        3.5.1 Mexico
        3.5.2 Brazil
        3.5.3 Argentina
        3.5.4 Others in Latin America
    3.6 Europe
        3.6.1 Germany
        3.6.2 United Kingdom
        3.6.3 France
        3.6.4 Italy
        3.6.5 Spain
        3.6.6 Russia
        3.6.7 Netherland
        3.6.8 Others in Europe
    3.7 Asia & Pacific
        3.7.1 China
        3.7.2 Japan
        3.7.3 India
        3.7.4 Korea
        3.7.5 Australia
        3.7.6 Southeast Asia
            3.7.6.1 Indonesia
            3.7.6.2 Thailand
            3.7.6.3 Philippines
            3.7.6.4 Vietnam
            3.7.6.5 Singapore
            3.7.6.6 Malaysia
            3.7.6.7 Others in Southeast Asia
    3.8 Africa & Middle East
        3.8.1 South Africa
        3.8.2 Egypt
        3.8.3 Turkey
        3.8.4 Saudi Arabia
        3.8.5 Iran
        3.8.6 Others in Africa & Middle East

Chapter Four Global Live Attenuated Vaccine by Companies 2012-2017
    4.1 Global Live Attenuated Vaccine Sales Volume Market Share by Companies 2012-2017
    4.2 Global Live Attenuated Vaccine Revenue Share by Companies 2012-2017
    4.3 Global Top Companies Live Attenuated Vaccine Key Product Model and Market Performance
    4.4 Global Top Companies Live Attenuated Vaccine Key Target Consumers and Market Performance

Chapter Five United States Live Attenuated Vaccine by Companies 2012-2017
    5.1 United States Live Attenuated Vaccine Sales Volume Market Share by Companies 2012-2017
    5.2 United States Live Attenuated Vaccine Revenue Share by Companies 2012-2017
    5.3 United States Top Companies Live Attenuated Vaccine Key Product Model and Market Performance
    5.4 United States Top Companies Live Attenuated Vaccine Key Target Consumers and Market Performance

Chapter Six Global Live Attenuated Vaccine by Consumer 2012-2017
    6.1 Global Live Attenuated Vaccine Sales Market Share by Consumer 2012-2017
    6.2 Hospital
    6.3 Medical Center
    6.4 Others
    6.5 Consuming Habit and Preference

Chapter Seven Global Live Attenuated Vaccine by Consumer 2012-2017
    7.1 Global Live Attenuated Vaccine Sales Market Share by Consumer 2012-2017
    7.2 Hospital
    7.3 Medical Center
    7.4 Others
    7.5 Consuming Habit and Preference

Chapter Eight Top Companies Profile
    8.1 Astellas Pharma (Japan)
        8.1.1 Astellas Pharma (Japan) Company Details and Competitors
        8.1.2 Astellas Pharma (Japan) Key Live Attenuated Vaccine Models and Performance
        8.1.3 Astellas Pharma (Japan) Live Attenuated Vaccine Business SWOT Analysis and Forecast
        8.1.4 Astellas Pharma (Japan) Live Attenuated Vaccine Sales Volume Revenue Price Cost and Gross Margin
    8.2 CSL Limited (Australia)
        8.2.1 CSL Limited (Australia) Company Details and Competitors
        8.2.2 CSL Limited (Australia) Key Live Attenuated Vaccine Models and Performance
        8.2.3 CSL Limited (Australia) Live Attenuated Vaccine Business SWOT Analysis and Forecast
        8.2.4 CSL Limited (Australia) Live Attenuated Vaccine Sales Volume Revenue Price Cost and Gross Margin
    8.3 Emergent BioSolutions (U.S.)
        8.3.1 Emergent BioSolutions (U.S.) Company Details and Competitors
        8.3.2 Emergent BioSolutions (U.S.) Key Live Attenuated Vaccine Models and Performance
        8.3.3 Emergent BioSolutions (U.S.) Live Attenuated Vaccine Business SWOT Analysis and Forecast
        8.3.4 Emergent BioSolutions (U.S.) Live Attenuated Vaccine Sales Volume Revenue Price Cost and Gross Margin
    8.4 GlaxoSmithKline (U.K.)
        8.4.1 GlaxoSmithKline (U.K.) Company Details and Competitors
        8.4.2 GlaxoSmithKline (U.K.) Key Live Attenuated Vaccine Models and Performance
        8.4.3 GlaxoSmithKline (U.K.) Live Attenuated Vaccine Business SWOT Analysis and Forecast
        8.4.4 GlaxoSmithKline (U.K.) Live Attenuated Vaccine Sales Volume Revenue Price Cost and Gross Margin
    8.5 Johnson & Johnson (U.S.)
        8.5.1 Johnson & Johnson (U.S.) Company Details and Competitors
        8.5.2 Johnson & Johnson (U.S.) Key Live Attenuated Vaccine Models and Performance
        8.5.3 Johnson & Johnson (U.S.) Live Attenuated Vaccine Business SWOT Analysis and Forecast
        8.5.4 Johnson & Johnson (U.S.) Live Attenuated Vaccine Sales Volume Revenue Price Cost and Gross Margin
    8.6 MedImmune (U.S.)
        8.6.1 MedImmune (U.S.) Company Details and Competitors
        8.6.2 MedImmune (U.S.) Key Live Attenuated Vaccine Models and Performance
        8.6.3 MedImmune (U.S.) Live Attenuated Vaccine Business SWOT Analysis and Forecast
        8.6.4 MedImmune (U.S.) Live Attenuated Vaccine Sales Volume Revenue Price Cost and Gross Margin
    8.7 Merck & Co (U.S.)
        8.7.1 Merck & Co (U.S.) Company Details and Competitors
        8.7.2 Merck & Co (U.S.) Key Live Attenuated Vaccine Models and Performance
        8.7.3 Merck & Co (U.S.) Live Attenuated Vaccine Business SWOT Analysis and Forecast
        8.7.4 Merck & Co (U.S.) Live Attenuated Vaccine Sales Volume Revenue Price Cost and Gross Margin
    8.8 Pfizer (U.S.)
        8.8.1 Pfizer (U.S.) Company Details and Competitors
        8.8.2 Pfizer (U.S.) Key Live Attenuated Vaccine Models and Performance
        8.8.3 Pfizer (U.S.) Live Attenuated Vaccine Business SWOT Analysis and Forecast
        8.8.4 Pfizer (U.S.) Live Attenuated Vaccine Sales Volume Revenue Price Cost and Gross Margin
    8.9 Sanofi Pasteur (France)
        8.9.1 Sanofi Pasteur (France) Company Details and Competitors
        8.9.2 Sanofi Pasteur (France) Key Live Attenuated Vaccine Models and Performance
        8.9.3 Sanofi Pasteur (France) Live Attenuated Vaccine Business SWOT Analysis and Forecast
        8.9.4 Sanofi Pasteur (France) Live Attenuated Vaccine Sales Volume Revenue Price Cost and Gross Margin
    8.10 Serum Institute of India Pvt (India)
        8.10.1 Serum Institute of India Pvt (India) Company Details and Competitors
        8.10.2 Serum Institute of India Pvt (India) Key Live Attenuated Vaccine Models and Performance
        8.10.3 Serum Institute of India Pvt (India) Live Attenuated Vaccine Business SWOT Analysis and Forecast
        8.10.4 Serum Institute of India Pvt (India) Live Attenuated Vaccine Sales Volume Revenue Price Cost and Gross Margin

Chapter Nine Industry Chain and Supply Chain
    9.1 Live Attenuated Vaccine Industry Chain Structure
        9.1.1 R&D
        9.1.2 Raw Materials (Components)
        9.1.3 Manufacturing Plants
        9.1.4 Regional Trading (Import Export and Local Sales)
        9.1.5 Online Sales Channel
        9.1.6 Offline Channel
        9.1.7 End Users
    9.2 Live Attenuated Vaccine Manufacturing
        9.2.1 Key Components
        9.2.2 Assembly Manufacturing
    9.3 Consumer Preference
    9.4 Behavioral Habits
    9.5 Marketing Environment

Chapter Ten Global Live Attenuated Vaccine Market Size (Sales and Revenue) Forecast (2017-2022)
    10.1 Global Live Attenuated Vaccine Sales (K Pcs), Revenue (Million USD) Forecast (2017-2022)
    10.2 Global Live Attenuated Vaccine Sales (K Pcs) Forecast by Regions (2017-2022)
    10.3 Global Live Attenuated Vaccine Sales (K Pcs) Forecast by Application (2017-2022)
    10.4 Global Live Attenuated Vaccine Sales (K Pcs) Forecast by End User (2017-2022)
    10.5 Global Live Attenuated Vaccine Sales (K Pcs) Forecast by Disease Indication (2017-2022)

Chapter Eleven United States Live Attenuated Vaccine Market Size (Sales and Revenue) Forecast (2017-2022)
    11.1 United States Live Attenuated Vaccine Sales (K Pcs), Revenue (Million USD) Forecast (2017-2022)
    11.2 United States Live Attenuated Vaccine Sales (K Pcs) Forecast by Regions (2017-2022)
    11.3 United States Live Attenuated Vaccine Sales (K Pcs) Forecast by Application (2017-2022)
    11.4 United States Live Attenuated Vaccine Sales (K Pcs) Forecast by End User (2017-2022)
    11.5 United States Live Attenuated Vaccine Sales (K Pcs) Forecast by Disease Indication (2017-2022)

Chapter Twelve Development Trend and Research Conclusion
    12.1 Development Trend
    12.2 Research Conclusion

Chapter Thirteen Methodology and Data Source
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer

List of Tables and Figures

    Table Global Live Attenuated Vaccine Sales Volume (K Pcs), Revenue (Million USD) and Price (USD/Pcs)(2012-2017)
    Figure Global Live Attenuated Vaccine Revenue (Million USD) and Growth Rate (2012-2017)
    Figure Global Live Attenuated Vaccine Sales Volume (K Pcs) and Growth Rate (2012-2017)
    Table Global Live Attenuated Vaccine Sales (K Pcs) by End User (2012-2017)
    Table Global Live Attenuated Vaccine Sales Market Share by End User (2012-2017)
    Figure Global Live Attenuated Vaccine Sales Market Share by End User in 2016
    Table Global Live Attenuated Vaccine Revenue (Million USD) by End User (2012-2017)
    Table Global Live Attenuated Vaccine Revenue Market Share by End User (2012-2017)
    Figure Global Live Attenuated Vaccine Revenue Market Share by End User in 2016
    Table Global Live Attenuated Vaccine Price (USD/Pcs) by End User (2012-2017)
    Table Top Companies of Pediatrics Live Attenuated Vaccine Products List
    Figure Global Pediatrics Live Attenuated Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
    Table Top Companies of Adults Live Attenuated Vaccine Products List
    Figure Global Adults Live Attenuated Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
    Table Global Live Attenuated Vaccine Sales (K Pcs) by Disease Indication (2012-2017)
    Table Global Live Attenuated Vaccine Sales Market Share by Disease Indication (2012-2017)
    Figure Global Live Attenuated Vaccine Sales Market Share by Disease Indication in 2016
    Table Global Live Attenuated Vaccine Revenue (Million USD) by Disease Indication (2012-2017)
    Table Global Live Attenuated Vaccine Revenue Market Share by Disease Indication (2012-2017)
    Figure Global Live Attenuated Vaccine Revenue Market Share by Disease Indication in 2016
    Table Global Live Attenuated Vaccine Price (USD/Pcs) by Disease Indication (2012-2017)
    Table Top Companies of Pneumococcal Live Attenuated Vaccine Products List
    Figure Global Pneumococcal Live Attenuated Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
    Table Top Companies of Influenza Live Attenuated Vaccine Products List
    Figure Global Influenza Live Attenuated Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
    Table Top Companies of HPV Live Attenuated Vaccine Products List
    Figure Global HPV Live Attenuated Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
    Table Top Companies of Hepatitis Live Attenuated Vaccine Products List
    Figure Global Hepatitis Live Attenuated Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
    Table Top Companies of Rotavirus Live Attenuated Vaccine Products List
    Figure Global Rotavirus Live Attenuated Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
    Figure United States Live Attenuated Vaccine Revenue (Million USD) and Growth Rate (2012-2017)
    Figure United States Live Attenuated Vaccine Sales Volume (K Pcs) and Growth Rate (2012-2017)
    Table United States Live Attenuated Vaccine Sales (K Pcs) by End User (2012-2017)
    Table United States Live Attenuated Vaccine Sales Market Share by End User (2012-2017)
    Figure United States Live Attenuated Vaccine Sales Market Share by End User in 2016
    Table United States Live Attenuated Vaccine Revenue (Million USD) by End User (2012-2017)
    Table United States Live Attenuated Vaccine Revenue Market Share by End User (2012-2017)
    Figure United States Live Attenuated Vaccine Revenue Market Share by End User in 2016
    Table United States Live Attenuated Vaccine Price (USD/Pcs) by End User (2012-2017)
    Table Top Companies of Pediatrics Live Attenuated Vaccine Products List
    Figure United States Pediatrics Live Attenuated Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
    Table Top Companies of Adults Live Attenuated Vaccine Products List
    Figure United States Adults Live Attenuated Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
    Table United States Live Attenuated Vaccine Sales (K Pcs) by Disease Indication (2012-2017)
    Table United States Live Attenuated Vaccine Sales Market Share by Disease Indication (2012-2017)
    Figure United States Live Attenuated Vaccine Sales Market Share by Disease Indication in 2016
    Table United States Live Attenuated Vaccine Revenue (Million USD) by Disease Indication (2012-2017)
    Table United States Live Attenuated Vaccine Revenue Market Share by Disease Indication (2012-2017)
    Figure United States Live Attenuated Vaccine Revenue Market Share by Disease Indication in 2016
    Table United States Live Attenuated Vaccine Price (USD/Pcs) by Disease Indication (2012-2017)
    Table Top Companies of Pneumococcal Live Attenuated Vaccine Products List
    Figure United States Pneumococcal Live Attenuated Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
    Table Top Companies of Influenza Live Attenuated Vaccine Products List
    Figure United States Influenza Live Attenuated Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
    Table Top Companies of HPV Live Attenuated Vaccine Products List
    Figure United States HPV Live Attenuated Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
    Table Top Companies of Hepatitis Live Attenuated Vaccine Products List
    Figure United States Hepatitis Live Attenuated Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
    Table Top Companies of Rotavirus Live Attenuated Vaccine Products List
    Figure United States Rotavirus Live Attenuated Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
    Table Global Live Attenuated Vaccine Sales (K Pcs) by Regions (2012-2017)
    Table Global Live Attenuated Vaccine Sales Share by Regions (2012-2017)
    Figure Global Live Attenuated Vaccine Sales Market Share by Regions in 2016
    Figure Global Live Attenuated Vaccine Sales Market Share by Regions in 2017
    Table Global Live Attenuated Vaccine Revenue (Million USD) and Market Share by Regions (2012-2017)
    Table Global Live Attenuated Vaccine Revenue Market Share by Regions (2012-2017)
    Figure Global Live Attenuated Vaccine Revenue Market Share by Regions in 2016
    Figure Global Live Attenuated Vaccine Revenue Market Share by Regions in 2017
    Table Global Live Attenuated Vaccine Price (USD/Pcs) by Regions (2012-2017)
    Table North America Live Attenuated Vaccine Sales (K Pcs) by Regions (2012-2017)
    Table North America Live Attenuated Vaccine Revenue (Million USD) by Regions (2012-2017)
    Figure North America Live Attenuated Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
    Table United States Live Attenuated Vaccine Sales (K Pcs) by Regions (2012-2017)
    Table United States Live Attenuated Vaccine Revenue (Million USD) by Regions (2012-2017)
    Figure United States Live Attenuated Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
    Table Latin America Live Attenuated Vaccine Sales (K Pcs) by Regions (2012-2017)
    Table Latin America Live Attenuated Vaccine Revenue (Million USD) by Regions (2012-2017)
    Figure Latin America Live Attenuated Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
    Table Europe Live Attenuated Vaccine Sales (K Pcs) by Regions (2012-2017)
    Table Europe Live Attenuated Vaccine Revenue (Million USD) by Regions (2012-2017)
    Figure Europe Live Attenuated Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
    Table Asia & Pacific Live Attenuated Vaccine Sales (K Pcs) by Regions (2012-2017)
    Table Asia & Pacific Live Attenuated Vaccine Revenue (Million USD) by Regions (2012-2017)
    Figure Asia & Pacific Live Attenuated Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
    Table Africa & Middle East Live Attenuated Vaccine Sales (K Pcs) by Regions (2012-2017)
    Table Africa & Middle East Live Attenuated Vaccine Revenue (Million USD) by Regions (2012-2017)
    Figure Africa & Middle East Live Attenuated Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
    Table Global Live Attenuated Vaccine Sales Volume (K Pcs) by Major Companies (2012-2017)
    Table Global Live Attenuated Vaccine Sales Volume Market Share by Major Companies (2012-2017)
    Figure Global Live Attenuated Vaccine Sales Volume Market Share by Major Companies 2016
    Figure Global Live Attenuated Vaccine Sales Volume Market Share by Major Companies 2017
    Table Global Live Attenuated Vaccine Revenue (Million USD) by Major Companies (2012-2017)
    Table Global Live Attenuated Vaccine Revenue Market Share by Major Companies (2012-2017)
    Figure Global Live Attenuated Vaccine Revenue Market Share by Major Companies 2016
    Figure Global Live Attenuated Vaccine Revenue Market Share by Major Companies 2017
    Table Global Top Companies Key Product Model and Market Performance
    Table Global Top Companies Key Target Consumers and Market Performance
    Table United States Live Attenuated Vaccine Sales Volume (K Pcs) by Top Companies (2012-2017)
    Table United States Live Attenuated Vaccine Sales Volume Market Share by Top Companies (2012-2017)
    Figure United States Live Attenuated Vaccine Sales Volume Market Share by Top Companies 2016
    Figure United States Live Attenuated Vaccine Sales Volume Market Share by Top Companies 2017
    Table United States Live Attenuated Vaccine Revenue (Million USD) by Top Companies (2012-2017)
    Table United States Live Attenuated Vaccine Revenue Market Share by Top Companies (2012-2017)
    Figure United States Live Attenuated Vaccine Revenue Market Share by Top Companies 2016
    Figure United States Live Attenuated Vaccine Revenue Market Share by Top Companies 2017
    Table United States Top Companies Key Product Model and Market Performance
    Table United States Top Companies Key Target Consumers and Market Performance
    Table Global Live Attenuated Vaccine Sales (K Pcs) by Consumer (2012-2017)
    Figure Global Live Attenuated Vaccine Sales Market Share by Consumer (2012-2017)
    Figure Global Live Attenuated Vaccine Sales Market Share by Consumer in 2016
    Figure Global Hospital Live Attenuated Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
    Figure Global Medical Center Live Attenuated Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
    Figure Global Others Live Attenuated Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
    Table United States Live Attenuated Vaccine Sales (K Pcs) by Consumer (2012-2017)
    Figure United States Live Attenuated Vaccine Sales Market Share by Consumer (2012-2017)
    Figure United States Live Attenuated Vaccine Sales Market Share by Consumer in 2016
    Figure United States Hospital Live Attenuated Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
    Figure United States Medical Center Live Attenuated Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
    Figure United States Others Live Attenuated Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
    Table Astellas Pharma (Japan) Company Details and Competitors
    Table Astellas Pharma (Japan) Key Live Attenuated Vaccine Models and Performance
    Table Astellas Pharma (Japan) Live Attenuated Vaccine Business SWOT Analysis and Forecast
    Table Astellas Pharma (Japan) Live Attenuated Vaccine Output (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
    Figure Astellas Pharma (Japan) Live Attenuated Vaccine Sales (Million Unit) and Growth Rate (%)(2012-2017)
    Figure Astellas Pharma (Japan) Live Attenuated Vaccine Sales Market Share (%) in Global (2012-2017)
    Figure Astellas Pharma (Japan) Live Attenuated Vaccine Sales Revenue (Million USD) and Growth Rate (%)(2012-2017)
    Figure Astellas Pharma (Japan) Live Attenuated Vaccine Revenue Market Share (%) in Global (2012-2017)
    Table CSL Limited (Australia) Company Details and Competitors
    Table CSL Limited (Australia) Key Live Attenuated Vaccine Models and Performance
    Table CSL Limited (Australia) Live Attenuated Vaccine Business SWOT Analysis and Forecast
    Table CSL Limited (Australia) Live Attenuated Vaccine Output (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
    Figure CSL Limited (Australia) Live Attenuated Vaccine Sales (Million Unit) and Growth Rate (%)(2012-2017)
    Figure CSL Limited (Australia) Live Attenuated Vaccine Sales Market Share (%) in Global (2012-2017)
    Figure CSL Limited (Australia) Live Attenuated Vaccine Sales Revenue (Million USD) and Growth Rate (%)(2012-2017)
    Figure CSL Limited (Australia) Live Attenuated Vaccine Revenue Market Share (%) in Global (2012-2017)
    Table Emergent BioSolutions (U.S.) Company Details and Competitors
    Table Emergent BioSolutions (U.S.) Key Live Attenuated Vaccine Models and Performance
    Table Emergent BioSolutions (U.S.) Live Attenuated Vaccine Business SWOT Analysis and Forecast
    Table Emergent BioSolutions (U.S.) Live Attenuated Vaccine Output (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
    Figure Emergent BioSolutions (U.S.) Live Attenuated Vaccine Sales (Million Unit) and Growth Rate (%)(2012-2017)
    Figure Emergent BioSolutions (U.S.) Live Attenuated Vaccine Sales Market Share (%) in Global (2012-2017)
    Figure Emergent BioSolutions (U.S.) Live Attenuated Vaccine Sales Revenue (Million USD) and Growth Rate (%)(2012-2017)
    Figure Emergent BioSolutions (U.S.) Live Attenuated Vaccine Revenue Market Share (%) in Global (2012-2017)
    Table GlaxoSmithKline (U.K.) Company Details and Competitors
    Table GlaxoSmithKline (U.K.) Key Live Attenuated Vaccine Models and Performance
    Table GlaxoSmithKline (U.K.) Live Attenuated Vaccine Business SWOT Analysis and Forecast
    Table GlaxoSmithKline (U.K.) Live Attenuated Vaccine Output (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
    Figure GlaxoSmithKline (U.K.) Live Attenuated Vaccine Sales (Million Unit) and Growth Rate (%)(2012-2017)
    Figure GlaxoSmithKline (U.K.) Live Attenuated Vaccine Sales Market Share (%) in Global (2012-2017)
    Figure GlaxoSmithKline (U.K.) Live Attenuated Vaccine Sales Revenue (Million USD) and Growth Rate (%)(2012-2017)
    Figure GlaxoSmithKline (U.K.) Live Attenuated Vaccine Revenue Market Share (%) in Global (2012-2017)
    Table Johnson & Johnson (U.S.) Company Details and Competitors
    Table Johnson & Johnson (U.S.) Key Live Attenuated Vaccine Models and Performance
    Table Johnson & Johnson (U.S.) Live Attenuated Vaccine Business SWOT Analysis and Forecast
    Table Johnson & Johnson (U.S.) Live Attenuated Vaccine Output (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
    Figure Johnson & Johnson (U.S.) Live Attenuated Vaccine Sales (Million Unit) and Growth Rate (%)(2012-2017)
    Figure Johnson & Johnson (U.S.) Live Attenuated Vaccine Sales Market Share (%) in Global (2012-2017)
    Figure Johnson & Johnson (U.S.) Live Attenuated Vaccine Sales Revenue (Million USD) and Growth Rate (%)(2012-2017)
    Figure Johnson & Johnson (U.S.) Live Attenuated Vaccine Revenue Market Share (%) in Global (2012-2017)
    Table MedImmune (U.S.) Company Details and Competitors
    Table MedImmune (U.S.) Key Live Attenuated Vaccine Models and Performance
    Table MedImmune (U.S.) Live Attenuated Vaccine Business SWOT Analysis and Forecast
    Table MedImmune (U.S.) Live Attenuated Vaccine Output (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
    Figure MedImmune (U.S.) Live Attenuated Vaccine Sales (Million Unit) and Growth Rate (%)(2012-2017)
    Figure MedImmune (U.S.) Live Attenuated Vaccine Sales Market Share (%) in Global (2012-2017)
    Figure MedImmune (U.S.) Live Attenuated Vaccine Sales Revenue (Million USD) and Growth Rate (%)(2012-2017)
    Figure MedImmune (U.S.) Live Attenuated Vaccine Revenue Market Share (%) in Global (2012-2017)
    Table Merck & Co (U.S.) Company Details and Competitors
    Table Merck & Co (U.S.) Key Live Attenuated Vaccine Models and Performance
    Table Merck & Co (U.S.) Live Attenuated Vaccine Business SWOT Analysis and Forecast
    Table Merck & Co (U.S.) Live Attenuated Vaccine Output (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
    Figure Merck & Co (U.S.) Live Attenuated Vaccine Sales (Million Unit) and Growth Rate (%)(2012-2017)
    Figure Merck & Co (U.S.) Live Attenuated Vaccine Sales Market Share (%) in Global (2012-2017)
    Figure Merck & Co (U.S.) Live Attenuated Vaccine Sales Revenue (Million USD) and Growth Rate (%)(2012-2017)
    Figure Merck & Co (U.S.) Live Attenuated Vaccine Revenue Market Share (%) in Global (2012-2017)
    Table Pfizer (U.S.) Company Details and Competitors
    Table Pfizer (U.S.) Key Live Attenuated Vaccine Models and Performance
    Table Pfizer (U.S.) Live Attenuated Vaccine Business SWOT Analysis and Forecast
    Table Pfizer (U.S.) Live Attenuated Vaccine Output (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
    Figure Pfizer (U.S.) Live Attenuated Vaccine Sales (Million Unit) and Growth Rate (%)(2012-2017)
    Figure Pfizer (U.S.) Live Attenuated Vaccine Sales Market Share (%) in Global (2012-2017)
    Figure Pfizer (U.S.) Live Attenuated Vaccine Sales Revenue (Million USD) and Growth Rate (%)(2012-2017)
    Figure Pfizer (U.S.) Live Attenuated Vaccine Revenue Market Share (%) in Global (2012-2017)
    Table Sanofi Pasteur (France) Company Details and Competitors
    Table Sanofi Pasteur (France) Key Live Attenuated Vaccine Models and Performance
    Table Sanofi Pasteur (France) Live Attenuated Vaccine Business SWOT Analysis and Forecast
    Table Sanofi Pasteur (France) Live Attenuated Vaccine Output (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
    Figure Sanofi Pasteur (France) Live Attenuated Vaccine Sales (Million Unit) and Growth Rate (%)(2012-2017)
    Figure Sanofi Pasteur (France) Live Attenuated Vaccine Sales Market Share (%) in Global (2012-2017)
    Figure Sanofi Pasteur (France) Live Attenuated Vaccine Sales Revenue (Million USD) and Growth Rate (%)(2012-2017)
    Figure Sanofi Pasteur (France) Live Attenuated Vaccine Revenue Market Share (%) in Global (2012-2017)
    Table Serum Institute of India Pvt (India) Company Details and Competitors
    Table Serum Institute of India Pvt (India) Key Live Attenuated Vaccine Models and Performance
    Table Serum Institute of India Pvt (India) Live Attenuated Vaccine Business SWOT Analysis and Forecast
    Table Serum Institute of India Pvt (India) Live Attenuated Vaccine Output (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
    Figure Serum Institute of India Pvt (India) Live Attenuated Vaccine Sales (Million Unit) and Growth Rate (%)(2012-2017)
    Figure Serum Institute of India Pvt (India) Live Attenuated Vaccine Sales Market Share (%) in Global (2012-2017)
    Figure Serum Institute of India Pvt (India) Live Attenuated Vaccine Sales Revenue (Million USD) and Growth Rate (%)(2012-2017)
    Figure Serum Institute of India Pvt (India) Live Attenuated Vaccine Revenue Market Share (%) in Global (2012-2017)
    Figure Global Live Attenuated Vaccine Sales (K Pcs) and Growth Rate (%) Forecast (2017-2022)
    Figure Global Live Attenuated Vaccine Revenue (Million USD) and Growth Rate Forecast (2017-2022)
    Figure Global Live Attenuated Vaccine Price (USD/Pcs) Trend Forecast (2017-2022)
    Table Global Live Attenuated Vaccine Sales (K Pcs) Forecast by Regions (2017-2022)
    Table Global Live Attenuated Vaccine Sales Volume Share Forecast by Regions (2017-2022)
    Figure Global Live Attenuated Vaccine Sales Volume Share Forecast by Regions (2017-2022)
    Figure Global Live Attenuated Vaccine Sales Volume Share Forecast by Regions in 2022
    Table Global Live Attenuated Vaccine Sales (K Pcs) Forecast by Application (2017-2022)
    Figure Global Live Attenuated Vaccine Sales Volume Market Share Forecast by Application (2017-2022)
    Figure Global Live Attenuated Vaccine Sales Volume Market Share Forecast by Application in 2022
    Table Global Live Attenuated Vaccine Sales (K Pcs) Forecast by End User (2017-2022)
    Figure Global Live Attenuated Vaccine Sales (K Pcs) Forecast by End User (2017-2022)
    Figure Global Live Attenuated Vaccine Sales Volume Market Share Forecast by End User in 2022
    Table Global Live Attenuated Vaccine Sales (K Pcs) Forecast by Disease Indication (2017-2022)
    Figure Global Live Attenuated Vaccine Sales (K Pcs) Forecast by Disease Indication (2017-2022)
    Figure Global Live Attenuated Vaccine Sales Volume Market Share Forecast by Disease Indication in 2022
    Figure United States Live Attenuated Vaccine Sales (K Pcs) and Growth Rate (%) Forecast (2017-2022)
    Figure United States Live Attenuated Vaccine Revenue (Million USD) and Growth Rate Forecast (2017-2022)
    Figure United States Live Attenuated Vaccine Price (USD/Pcs) Trend Forecast (2017-2022)
    Table United States Live Attenuated Vaccine Sales (K Pcs) Forecast by Regions (2017-2022)
    Table United States Live Attenuated Vaccine Sales Volume Share Forecast by Regions (2017-2022)
    Figure United States Live Attenuated Vaccine Sales Volume Share Forecast by Regions (2017-2022)
    Figure United States Live Attenuated Vaccine Sales Volume Share Forecast by Regions in 2022
    Table United States Live Attenuated Vaccine Sales (K Pcs) Forecast by Application (2017-2022)
    Figure United States Live Attenuated Vaccine Sales Volume Market Share Forecast by Application (2017-2022)
    Figure United States Live Attenuated Vaccine Sales Volume Market Share Forecast by Application in 2022
    Table United States Live Attenuated Vaccine Sales (K Pcs) Forecast by End User (2017-2022)
    Figure United States Live Attenuated Vaccine Sales (K Pcs) Forecast by End User (2017-2022)
    Figure United States Live Attenuated Vaccine Sales Volume Market Share Forecast by End User in 2022
    Table United States Live Attenuated Vaccine Sales (K Pcs) Forecast by Disease Indication (2017-2022)
    Figure United States Live Attenuated Vaccine Sales (K Pcs) Forecast by Disease Indication (2017-2022)
    Figure United States Live Attenuated Vaccine Sales Volume Market Share Forecast by Disease Indication in 2022